These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7901986)

  • 1. A symposium: Controlling Cardiac Arrhythmias by Lengthening Repolarization: Emerging Perspectives. Proceedings. New Orleans, Louisiana, November 15, 1992.
    Am J Cardiol; 1993 Nov; 72(16):1F-124F. PubMed ID: 7901986
    [No Abstract]   [Full Text] [Related]  

  • 2. Changing Trends in Antiarrhythmic Therapy: Worldwide Experience with Class III Agents. Symposium proceedings. New Orleans, Louisiana, November 10, 1996.
    Am J Cardiol; 1997 Oct; 80(8A):1G-104G. PubMed ID: 9382031
    [No Abstract]   [Full Text] [Related]  

  • 3. Approaches to Controlling Cardiac Arrhythmias: Focus on Amiodarone, the Last 15 Years. Proceedings of a symposium. Dallas, Texas, USA. November 7, 1998.
    Am J Cardiol; 1999 Nov; 84(9A):1R-173R. PubMed ID: 10610617
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlling cardiac arrhythmias by lengthening repolarization: rationale from experimental findings and clinical considerations.
    Singh BN; Sarma JS; Zhang ZH; Takanaka C
    Ann N Y Acad Sci; 1992 Jan; 644():187-209. PubMed ID: 1314032
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical scope of disopyramide. A clinical symposium. San Antonio, Texas, November 5, 1984. Proceedings.
    Angiology; 1987 Feb; 38(2 Pt 2):165-204. PubMed ID: 3103490
    [No Abstract]   [Full Text] [Related]  

  • 6. Changing Perspectives in Cardiac Arrhythmia Control: Agents, Techniques, Goals, and Outcomes. Symposium proceedings. Dallas, Texas, November 13, 1994.
    J Cardiovasc Electrophysiol; 1995 Oct; 6(10 Pt 2):865-978. PubMed ID: 8548107
    [No Abstract]   [Full Text] [Related]  

  • 7. The management of cardiac arrhythmias: The role of encainide and sotalol. A symposium. March 24-25, 1988. Proceedings.
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():531-634. PubMed ID: 1980421
    [No Abstract]   [Full Text] [Related]  

  • 8. Class III Antiarrhythmic Drugs: Potential Impact on Arrhythmia Therapy. Symposium proceedings. Nice, France, 17 June 1992.
    Eur Heart J; 1993 Nov; 14 Suppl H():1-99. PubMed ID: 7904933
    [No Abstract]   [Full Text] [Related]  

  • 9. Symposium on High Risk Arrhythmia: Its Mechanism and Treatment. 51st annual scientific session of the Japanese Circulation Society. March 31, 1987, Tokyo.
    Jpn Circ J; 1988 Mar; 52(3):229-305. PubMed ID: 3373714
    [No Abstract]   [Full Text] [Related]  

  • 10. Potassium, magnesium, and cardiovascular morbidity. Proceedings of a symposium. November 10, 1985, Washington, D.C.
    Am J Med; 1986 Apr; 80(4A):1-36. PubMed ID: 3706348
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy of tachyarrhythmias, benefits and risks. Proceedings of a symposium. Düsseldorf, 11 July 1984.
    Drugs; 1985; 29 Suppl 4():1-88. PubMed ID: 4006775
    [No Abstract]   [Full Text] [Related]  

  • 12. A symposium: Pharmacological management of ventricular arrhythmias--current status in the role of moricizine HCl. October 19-22, 1989, Scottsdale, Arizona. Proceedings.
    Am J Cardiol; 1990 Feb; 65(8):1D-71D. PubMed ID: 2407087
    [No Abstract]   [Full Text] [Related]  

  • 13. Sotalol in Life-Threatening Ventricular Arrhythmias: A Unique Class III Antiarrhythmic. Symposium proceedings. Phoenix, Arizona, September 19-22, 1991.
    Am J Cardiol; 1993 Aug; 72(4):1A-85A. PubMed ID: 8102220
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of heart rhythm disorders in clinical practice. International symposium: New perspectives in the treatment of class III antiarrhythmics. 20 May 1989, Brussels. Abstracts].
    Fortschr Med Suppl; 1989; 70():1-15. PubMed ID: 2807125
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac drugs: assessment of new concepts concerning the therapy of cardiac arrhythmias.
    Kleiber GE; Schwinghamer J
    J Am Osteopath Assoc; 1979 Jun; 78(10):744-52. PubMed ID: 468596
    [No Abstract]   [Full Text] [Related]  

  • 16. [Perspectives in anti-arrhythmia pharmacological therapy].
    Furlanello F; Vergara G; Inama G; Dal Forno P; Bettini R; Disertori M
    Cardiologia; 1984; 29(1-2):73-84. PubMed ID: 6442869
    [No Abstract]   [Full Text] [Related]  

  • 17. New drugs for the treatment of cardiac arrhythmias.
    Bump TE; Arnsdorf MF
    Compr Ther; 1980 Jun; 6(6):63-72. PubMed ID: 6103779
    [No Abstract]   [Full Text] [Related]  

  • 18. Beat-to-beat variability of repolarization: a new parameter to determine arrhythmic risk of an individual or identify proarrhythmic drugs.
    Oosterhoff P; Oros A; Vos MA
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():73-8. PubMed ID: 17584687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fetal cardiac arrhythmia. Clinical experience with anti-arrhythmia drugs].
    Blandón R; Leandro IM
    Rev Med Panama; 1986 May; 11(2):111-23. PubMed ID: 3749536
    [No Abstract]   [Full Text] [Related]  

  • 20. [Management of cardiac arrhythmias during pregnancy].
    Fennira S; Khaldi MH; Rejeb MA; Ellouze Y; Kraiem S; Slimane ML
    Ann Cardiol Angeiol (Paris); 2011 Apr; 60(2):97-101. PubMed ID: 21276587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.